SU-DHL-4 Cells


General information
Description | The SU-DHL-4 cell line is derived from a lymphoblast-like cell isolated from the peritoneal effusion of a 38-year-old Caucasian male patient. This cell line represents a model of diffuse large B-cell lymphoma (DLBCL), one of the most common types of non-Hodgkin lymphoma in adults. The establishment of this cell line has provided valuable insights into the biology of DLBCL, especially concerning the cellular and molecular mechanisms underlying lymphomagenesis and tumor progression. In research, SU-DHL-4 cells have been extensively utilized to study the efficacy and mechanism of action of various chemotherapeutic and targeted therapeutic agents, reflecting their importance in lymphoma treatment research. The cells express several key immunophenotypic markers associated with B-cell lineage such as CD19 and CD20, which are crucial for the development and function of B-lymphocytes. These markers also make SU-DHL-4 an excellent target for testing B-cell-specific therapies, including monoclonal antibodies and small molecule inhibitors that disrupt critical signaling pathways involved in lymphoma cell survival and proliferation. |
---|---|
Organism | Human |
Tissue | Peritoneal effusion |
Disease | Diffuse large B-cell lymphoma |
Synonyms | SUDHL4, Sudhl4, SUDHL-4, Sudhl-4, SuDHL 4, SUD-4, SUD4, SU4, Stanford University-Diffuse Histiocytic Lymphoma-4, DHL-4, DHL4 |
Characteristics
Age | 38 years |
---|---|
Gender | Male |
Ethnicity | European |
Morphology | Lymphoblast |
Growth properties | Suspension |
Identifiers / Biosafety / Citation
Citation | SU-DHL-4 (Cytion catalog number 305106) |
---|---|
Biosafety level | 1 |
Expression / Mutation
Protein expression | IgG+, Kappa+, IgM-, IgA-, IgD-, Lambda-, This cell line has relatively high expression levels of Bax, Bak, AIF, high caspase-9 activity. |
---|
Handling
Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
---|---|
Medium supplements | Supplement the medium with 10% FBS |
Doubling time | 40 hours |
Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 2 x 10^5 cells/ml and keep the cell concentration within the range of 1 x 10^5 to 1 x 10^6 cells/ml for optimal growth. |
Split ratio | 1:2 to 1:6 |
Fluid renewal | 2 to 3 times per week |
Freeze medium | As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
Handling of cryopreserved cultures |
|
Quality control / Genetic profile / HLA
Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
---|